MedTrace Logo

Altered and Conventional Fractionated Radiotherapy in Patients With Head and Neck Cancer

NCT00291434 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 152

Last updated 2006-05-04

No results posted yet for this study

Summary

The aim of our study was to evaluate the value of two different altered fractionation schedules - hyperfractionation and accelerated fractionation with concomitant boost - in comparison with conventional fractionation in primary definitive radiotherapy for squamous cell carcinomas of the larynx, oropharynx or hypopharynx. The study began and was conducted while the only teletherapy unit in our department was the cobalt-60 machine. During that period we were expecting the installation of new sophisticated equipment. We assumed that the results of this study would be also able to show whether or not it would be rational to use the altered fractionation regimens on the new machines.

Conditions

Sponsors & Collaborators

  • Institute of Radiotherapy and Oncology, Macedonia

    lead OTHER

Principal Investigators

  • Valentina B Krstevska · 2

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
1999-03-31
Completion
2005-06-30

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00291434 on ClinicalTrials.gov